Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with endometrial hyperplasia and endometrial cancer

Abstract

AimNeutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and platelet distribution width (PDW) may indicate the systemic inflammatory response associated with various cancers. We aimed to investigate the relationship between NLR, PLR, PDW and endometrial pathologies including hyperplasia and cancer. MethodsIn this study, 472 cases who underwent endometrial biopsy were included. Three groups were constituted with respect to biopsy results: group 1, endometrial cancer patients (n=54); group 2, endometrial hyperplasia patients (n=152); and group 3, patients with normal biopsy results (n=281). White blood cell and platelet counts as well as NLR, PLR and PDW recorded from complete blood counts obtained on the same day of biopsy were compared in the three groups. ResultsEndometrial cancer patients were significantly older than the cases in the other two groups (P<0.001). the NLR in group 1 was significantly higher than group 3 (P=0.02). However, there was no difference between the three groups with respect to PLR (P=0.167). PDW was increased in group 1 compared to group 3 (P<0.001). ConclusionResults of our study have shown that NLR, PLR and PDW are simple, readily available and robust inflammatory markers that may be used in the management of endometrial pathologies. However, the actual predictive potential of these biomarkers still warrants further trials.